Beckman Coulter Enters Commercial Dispute with Quidel to Sell BNP Directly

Food and Healthcare Press Releases Tuesday November 28, 2017 11:52
BREA, California--28 Nov--PRNewswire/InfoQuest

Beckman Coulter is committed to ensuring customers receive the highest quality assays, on-time, to help healthcare and laboratory professionals provide better patient care. To further these goals, Beckman Coulter plans in the future to sell directly to its customers a natriuretic peptide assay for its Access Family of Immunoassay Systems. Currently, Beckman Coulter customers have access to a BNP assay which, although developed and manufactured by Beckman Coulter, is sold exclusively by Quidel and its designated distributors. Quidel took over this commercial role as a result of its recent transaction with Alere.   Today, Beckman Coulter requested that the San Diego courts in California clarify and enforce Beckman Coulter's rights to sell a natriuretic peptide assay directly to its customers. While this legal matter is being resolved, Beckman Coulter's manufacture and supply of the TRIAGE(R) BNP assay to Quidel and Quidel's customer relationships are expected to continue as usual, and customers can therefore rely on continued and ongoing supply of high-quality BNP for use on Beckman Coulter analyzers.

About Beckman Coulter

Beckman Coulter Diagnostics helps healthcare and laboratory professionals provide better patient care by delivering the accurate diagnostic information they need, when they need it. For over 80 years, Beckman Coulter has been the partner of choice for healthcare organizations. Our scalable instruments, comprehensive diagnostic tests and business management services are trusted by hospitals, laboratories and other critical care settings around the world. We share in our customers' mission toward continuous improvement and quality patient care because we believe when efficiency and clinical outcomes are improved, patients benefit and we can move healthcare forward for every person.

(C) 2017 Beckman Coulter, the stylized logo and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.

Logo - http://mma.prnewswire.com/media/610417/BECKMAN_COULTER_LOGO.jpg

Latest Press Release

Medical Devices ASEAN 2018 supports the push to position Thailand as the medical hub of Asia

Medical Devices ASEAN 2018 ("MDA 2018") – the international exhibition and academic congress on medical devices, technologies, services and general healthcare – opens today and runs until Friday, 13 July 2018 at Hall 1-2, IMPACT Exhibition...

Berlinger Group Presents Arrangements for the Future Provision of Its World-renowned Anti-doping Products

- Distribution and further development of Berlinger anti-doping products to be entrusted to a foundation; Berlinger Board of Directors appoints new Group CEO The Swiss-based Berlinger Group (which comprises Berlinger & Co. AG and Berlinger Special...

Ideal Cures Launches Two New Film Coating Products INSTACOAT QD and INSTACOAT T2F at the 2nd FDD Conclave

Ideal Cures, an Indian company headquartered in Mumbai, India, launched two new ready-to-use film coating products INSTACOAT QD and INSTACOAT T2F, at the 2nd Formulation and Drug Delivery Conclave (FDD), held on 15th-16th June 2018, at Hyderabad, India...

A Century After Umami#s Discovery, Its Benefits Continue to Expand

Umami, known as the savory taste, was discovered more than a century ago, yet recent research continues to document the benefits of umami. Currently underway is a year-long recognition of umami's 110th anniversary since its discovery in 1908. At one...

Merck Launches Online Platform Fertility.com

- Offering the latest scientific information to healthcare professionals in the advancing field of fertility - Supporting women, men and couples who are looking for information about fertility and/or undergoing fertility treatment (Photo:...

Related Topics